Stephen Rocamboli - 16 May 2022 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role: Director
Signature: /s/ Stephen Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 16 May 2022
Net transactions value: +$13,620
Form type: 4
Filing time: 17 May 2022, 21:50:33 UTC
Previous filing: 28 Apr 2022
Next filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TFFP	Common Stock	Purchase	$13,620	+3,000	+19%	$4.54^*	18,722	16 May 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.